<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>56(4)</volume><submitter>Lutgring JD</submitter><pubmed_abstract>Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2%). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1%). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative pred</pubmed_abstract><journal>Journal of clinical microbiology</journal><pagination>e01672-17</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5869849</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.</pubmed_title><pmcid>PMC5869849</pmcid><pubmed_authors>Hollaway R</pubmed_authors><pubmed_authors>Burd EM</pubmed_authors><pubmed_authors>Bittencourt C</pubmed_authors><pubmed_authors>Cavuoti D</pubmed_authors><pubmed_authors>McElvania TeKippe E</pubmed_authors><pubmed_authors>Lutgring JD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.</name><description>Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2%). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1%). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative pred</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Apr</publication><modification>2025-04-04T19:45:05.367Z</modification><creation>2019-03-26T23:57:05Z</creation></dates><accession>S-EPMC5869849</accession><cross_references><pubmed>29386262</pubmed><doi>10.1128/JCM.01672-17</doi><doi>10.1128/jcm.01672-17</doi></cross_references></HashMap>